NASDAQ: AGENAgenus Inc Stock Ownership - Who owns Agenus?
Insider buying vs selling
Have Agenus Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Garo H. Armen | Chairman and Chief Executive Officer | 2025-06-27 | 3,436 | $4.76 | $16.36kBuy |
| Steven J. Oday | Chief Medical Officer | 2025-06-18 | 43,497 | $4.47 | $194.43kBuy |
| Christine M. Klaskin | PFO PAO | 2025-06-18 | 15,782 | $4.47 | $70.55kBuy |
| Garo H. Armen | Chairman and Chief Executive Officer | 2025-06-18 | 61,397 | $4.47 | $274.44kBuy |
| Garo H. Armen | Chairman and Chief Executive Officer | 2025-06-13 | 3,480 | $4.70 | $16.36kBuy |
| Garo H. Armen | Director | 2025-05-30 | 4,769 | $3.43 | $16.36kBuy |
| Garo H. Armen | Chairman and Chief Executive Officer | 2025-05-16 | 4,700 | $3.48 | $16.36kBuy |
| Jennifer Buell | Director | 2025-05-02 | 581 | $3.11 | $1.81kBuy |
| Garo H. Armen | Chairman and Chief Executive Officer | 2025-05-02 | 5,260 | $3.11 | $16.36kBuy |
| Garo H. Armen | Chairman and Chief Executive Officer | 2025-04-18 | 7,886 | $2.08 | $16.40kBuy |
AGEN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AGEN insiders and whales buy or sell their stock.
AGEN Shareholders
What type of owners hold Agenus Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Garo H. Armen | 362.42% | 99,363,383 | $480.92M | Insider |
| Incyte Corp | 61.91% | 16,972,968 | $82.15M | Insider |
| Qvt Associates GP LLC | 25.22% | 6,915,630 | $33.47M | Insider |
| Invus Public Equities LP | 12.89% | 3,533,333 | $17.10M | Insider |
| Vanguard Group Inc | 9.30% | 2,549,359 | $12.34M | Institution |
| Blackrock Inc | 6.39% | 1,752,636 | $8.48M | Institution |
| Shahzad Malik | 5.79% | 1,587,302 | $7.68M | Insider |
| Gamil De Chadarevian | 5.72% | 1,568,098 | $7.59M | Insider |
| Geode Capital Management LLC | 1.98% | 544,139 | $2.63M | Institution |
| Siren LLC | 1.82% | 500,000 | $2.42M | Institution |
AGEN vs Biotech Stocks
Agenus Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.